JCP174

CAS: 126062-19-9

Ref. 3D-BFA06219

Informação sobre produto

• Nome: JCP174

Descrição

JCP174 is a small molecule that inhibits the life cycle of Toxoplasma gondii. It encompasses the development of toxoplasmosis, which is a disease caused by this organism. JCP174 has been shown to be an achievable drug candidate for the treatment of toxoplasmosis and other diseases. The nature of JCP174's action against Toxoplasma gondii is unknown, but it may involve the disruption of the parasite's fatty acid synthesis. There are many techniques for profiling JCP174, including fluorogenic substrates and cellular assays. These techniques are useful in determining how to improve its potency, selectivity, and pharmacokinetics.

• Marca: Biosynth

Propriedades químicas

• Peso molecular: 253.68 g/mol
• Fórmula: C₁₂H₁₂ClNO₃
• Pureza: Min. 95%